MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes

Acute respiratory distress syndrome (ARDS) following cardiopulmonary bypass (CPB) is driven by oxidative stress during lung ischemia-reperfusion injury (LIRI). Mitochondrial-derived peptide MOTS-c has emerged as a regulator of mitochondrial-nuclear communication, yet its role in CPB-induced ARDS rem...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiangyu Li, Faliang Zhan, Guangfeng Qiu, Peng Lu, Zihao Shen, Yuanpu Qi, Minchao Wu, Mingyu Chu, Jia Feng, Ziang Wen, Xin Yao, Ao Wang, Wanjun Jin, Xiao Zhang, Junjie Liao, Jialin Zhang, Meijuan Song, Wei Wang, Xiaowei Wang
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231725001946
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850151679124570112
author Xiangyu Li
Faliang Zhan
Guangfeng Qiu
Peng Lu
Zihao Shen
Yuanpu Qi
Minchao Wu
Mingyu Chu
Jia Feng
Ziang Wen
Xin Yao
Ao Wang
Wanjun Jin
Xiao Zhang
Junjie Liao
Jialin Zhang
Meijuan Song
Wei Wang
Xiaowei Wang
author_facet Xiangyu Li
Faliang Zhan
Guangfeng Qiu
Peng Lu
Zihao Shen
Yuanpu Qi
Minchao Wu
Mingyu Chu
Jia Feng
Ziang Wen
Xin Yao
Ao Wang
Wanjun Jin
Xiao Zhang
Junjie Liao
Jialin Zhang
Meijuan Song
Wei Wang
Xiaowei Wang
author_sort Xiangyu Li
collection DOAJ
description Acute respiratory distress syndrome (ARDS) following cardiopulmonary bypass (CPB) is driven by oxidative stress during lung ischemia-reperfusion injury (LIRI). Mitochondrial-derived peptide MOTS-c has emerged as a regulator of mitochondrial-nuclear communication, yet its role in CPB-induced ARDS remains unclear. Here, we identify MOTS-c as a critical mediator of endothelial protection against LIRI through MYH9-dependent nuclear translocation and transcriptional activation of antioxidant genes. In rat LIRI models, endothelial cells exhibited the most significant MOTS-c upregulation, correlating with barrier preservation and reduced oxidative stress. Mechanistically, hypoxia-reoxygenation (HR) triggered reactive oxygen species (ROS)-dependent phosphorylation of MYH9 at Ser1943 via casein kinase II subunit alpha (CK2A), enabling MOTS-c binding to MYH9-γ-Actin complexes for nuclear transport. RNA sequencing (RNA-seq) combined with chromatin immunoprecipitation sequencing (ChIP-seq) revealed direct MOTS-c interaction with promoters of antioxidant genes (e.g., HMOX1, NQO1), which harbor antioxidant response elements (AREs). Clinically, serum MOTS-c increments within 24 h post-CPB (ΔMOTS-c) outperformed traditional biomarkers in predicting ARDS incidence, with multivariate models incorporating ΔMOTS-c achieving superior discriminative power (AUC = 0.885). Exogenous MOTS-c administration in rats attenuated lung injury by reducing oxidative damage, inflammation, and mortality, recapitulating endogenous protective mechanisms. Our findings establish MOTS-c as a dual-function molecule—acting via ROS-CK2A-MYH9 signaling to activate nuclear antioxidant defenses and serving as a prognostic biomarker for CPB-related complications. This study bridges mitochondrial dynamics, nuclear transcriptional regulation, and clinical outcomes, offering novel preventive avenues for IRI-associated pathologies.
format Article
id doaj-art-0b72c60833724231bbfeb9cf33c82f3e
institution OA Journals
issn 2213-2317
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj-art-0b72c60833724231bbfeb9cf33c82f3e2025-08-20T02:26:09ZengElsevierRedox Biology2213-23172025-07-018410368110.1016/j.redox.2025.103681MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genesXiangyu Li0Faliang Zhan1Guangfeng Qiu2Peng Lu3Zihao Shen4Yuanpu Qi5Minchao Wu6Mingyu Chu7Jia Feng8Ziang Wen9Xin Yao10Ao Wang11Wanjun Jin12Xiao Zhang13Junjie Liao14Jialin Zhang15Meijuan Song16Wei Wang17Xiaowei Wang18Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiothoracic Surgery, Yili Friendship Hospital, Yining, ChinaDepartment of Respiratory and Critical Care Medicine, Yili Friendship Hospital, Yining, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaDepartment of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; Corresponding author.Mazankowski Alberta Heart Institute, University of Alberta, Canada; Corresponding author.Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; Department of Cardiovascular Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China; Corresponding author. Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.Acute respiratory distress syndrome (ARDS) following cardiopulmonary bypass (CPB) is driven by oxidative stress during lung ischemia-reperfusion injury (LIRI). Mitochondrial-derived peptide MOTS-c has emerged as a regulator of mitochondrial-nuclear communication, yet its role in CPB-induced ARDS remains unclear. Here, we identify MOTS-c as a critical mediator of endothelial protection against LIRI through MYH9-dependent nuclear translocation and transcriptional activation of antioxidant genes. In rat LIRI models, endothelial cells exhibited the most significant MOTS-c upregulation, correlating with barrier preservation and reduced oxidative stress. Mechanistically, hypoxia-reoxygenation (HR) triggered reactive oxygen species (ROS)-dependent phosphorylation of MYH9 at Ser1943 via casein kinase II subunit alpha (CK2A), enabling MOTS-c binding to MYH9-γ-Actin complexes for nuclear transport. RNA sequencing (RNA-seq) combined with chromatin immunoprecipitation sequencing (ChIP-seq) revealed direct MOTS-c interaction with promoters of antioxidant genes (e.g., HMOX1, NQO1), which harbor antioxidant response elements (AREs). Clinically, serum MOTS-c increments within 24 h post-CPB (ΔMOTS-c) outperformed traditional biomarkers in predicting ARDS incidence, with multivariate models incorporating ΔMOTS-c achieving superior discriminative power (AUC = 0.885). Exogenous MOTS-c administration in rats attenuated lung injury by reducing oxidative damage, inflammation, and mortality, recapitulating endogenous protective mechanisms. Our findings establish MOTS-c as a dual-function molecule—acting via ROS-CK2A-MYH9 signaling to activate nuclear antioxidant defenses and serving as a prognostic biomarker for CPB-related complications. This study bridges mitochondrial dynamics, nuclear transcriptional regulation, and clinical outcomes, offering novel preventive avenues for IRI-associated pathologies.http://www.sciencedirect.com/science/article/pii/S2213231725001946Acute respiratory distress syndromeCardiopulmonary bypassIschemia reperfusion injuryOxidative stressMOTS-cMYH9
spellingShingle Xiangyu Li
Faliang Zhan
Guangfeng Qiu
Peng Lu
Zihao Shen
Yuanpu Qi
Minchao Wu
Mingyu Chu
Jia Feng
Ziang Wen
Xin Yao
Ao Wang
Wanjun Jin
Xiao Zhang
Junjie Liao
Jialin Zhang
Meijuan Song
Wei Wang
Xiaowei Wang
MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
Redox Biology
Acute respiratory distress syndrome
Cardiopulmonary bypass
Ischemia reperfusion injury
Oxidative stress
MOTS-c
MYH9
title MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
title_full MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
title_fullStr MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
title_full_unstemmed MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
title_short MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes
title_sort mots c attenuates lung ischemia reperfusion injury via myh9 dependent nuclear translocation and transcriptional activation of antioxidant genes
topic Acute respiratory distress syndrome
Cardiopulmonary bypass
Ischemia reperfusion injury
Oxidative stress
MOTS-c
MYH9
url http://www.sciencedirect.com/science/article/pii/S2213231725001946
work_keys_str_mv AT xiangyuli motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT faliangzhan motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT guangfengqiu motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT penglu motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT zihaoshen motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT yuanpuqi motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT minchaowu motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT mingyuchu motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT jiafeng motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT ziangwen motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT xinyao motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT aowang motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT wanjunjin motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT xiaozhang motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT junjieliao motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT jialinzhang motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT meijuansong motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT weiwang motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes
AT xiaoweiwang motscattenuateslungischemiareperfusioninjuryviamyh9dependentnucleartranslocationandtranscriptionalactivationofantioxidantgenes